Effects of Baduanjin Combined Balance Training on Gait and Posture Control of Patients with Mild and Moderate Parkinson's Disease

• Register: ChiCTR
• Last refreshed on: 10 July 2017
• Main ID: ChiCTR-IPR-17011875
• Date of registration: 2017-07-05
• Prospective Registration: Yes
• Primary sponsor: Affiliated Lianyungang Hospital of Xuzhou Medical University
• Public title: Effects of Baduanjin Combined Balance Training on Gait and Posture Control of Patients with Mild and Moderate Parkinson's Disease
• Scientific title: Effects of Baduanjin Combined Balance Training on Gait and Posture Control of Patients with Mild and Moderate Parkinson's Disease
• Date of first enrolment: 2017-08-01
• Target sample size: Control group:30;Baduanjin group:30;Balance function training group:30;
• Recruitment status: Pending
• URL: http://www.chictr.org.cn/showproj.aspx?proj=20281
• Study type: Interventional study
• Study design: Randomized parallel controlled trial
• Phase: Pilot study

Countries of recruitment

China

Contacts

• Name: Zenglin Cai
• Affiliation: Affiliated Lianyungang Hospital of Xuzhou Medical University

• Name: Zenglin Cai
• Affiliation: Affiliated Lianyungang Hospital of Xuzhou Medical University

Key inclusion & exclusion criteria

Inclusion criteria: 1. a clear diagnosis of primary Parkinson's disease,
Meet the 2013 Criteria of Guidelines for the diagnosis of Parkinson 's disease of European Neurological Union:
1) reduced capasity of movement;
2) meets at least one of the following clinical manifestations, including muscle rigidity; resting tremor; posture instability.
3) at least meet the following criteria: unilateral disease; resting tremor; disease progressively progress; after the onset of persistent asymmetric involvement; levodopa treatment at first effective;
2. Hoehn-Yahr grade 1-3, able to walk independently;
3. 1 week before the election to the beginning of the trial did not adjust the drug, medication during treatment unchanged;
4. auditory, visual and cognitive ability is normal.
Exclusion criteria: (1) various secondary Parkinson's syndrome (including traumatic, drug-induced, tumor, vascular, toxic, hydrocephalus, etc.) and Parkinson's syndrome;
(2) previous bone and joint disease or cerebrovascular disease, and the impact of walking or balance function;
(3) heart failure, severe hypertension and other serious medical diseases;
(4) do not cooperate with the inspection and training.

Age minimum: 40
Age maximum: 80
Gender: Both

Health Condition(s) or Problem(s) studied

Parkinson's Disease

Intervention(s)

Control group:Conventional drug therapy;Baduanjin group:Baduanjin aerobic exercise;Balance function training group:Balance function training group;

Primary Outcome(s)

The bulk sensory mean index (A.T.E);Gait test results;

Secondary Outcome(s)

Unified Parkinson’S Disease Rating Scale,UPDRS;Serum Tyrosine hydroxylase,TH;Serum HVA;Serum alpha-synuclein;

Source(s) of Monetary Support

Self-financing